Investigation of Pharmacokinetic Properties of Single Subcutaneous Doses of NNC0194-0499 in Chinese Males
Latest Information Update: 12 Jun 2024
At a glance
- Drugs NNC0194 0499 (Primary)
- Indications Non-alcoholic steatohepatitis
- Focus Pharmacokinetics
- Sponsors Novo Nordisk
Most Recent Events
- 27 Jun 2023 Status changed from recruiting to completed.
- 30 Mar 2023 Status changed from not yet recruiting to recruiting.
- 28 Feb 2023 New trial record